Sanofi-Aventis SA reported fourth- quarter profit that beat analysts’ estimates after swine flu vaccine sales helped offset revenue lost to generic rivals.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.